JP2023530120A5 - - Google Patents
Info
- Publication number
- JP2023530120A5 JP2023530120A5 JP2022576866A JP2022576866A JP2023530120A5 JP 2023530120 A5 JP2023530120 A5 JP 2023530120A5 JP 2022576866 A JP2022576866 A JP 2022576866A JP 2022576866 A JP2022576866 A JP 2022576866A JP 2023530120 A5 JP2023530120 A5 JP 2023530120A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical product
- product according
- kinase inhibitor
- patient
- fasudil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063039141P | 2020-06-15 | 2020-06-15 | |
| US63/039,141 | 2020-06-15 | ||
| US202063046173P | 2020-06-30 | 2020-06-30 | |
| US63/046,173 | 2020-06-30 | ||
| PCT/US2021/012590 WO2021257122A1 (en) | 2020-06-15 | 2021-01-08 | Methods of using rho kinase inhibitors to treat vascular dementia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023530120A JP2023530120A (ja) | 2023-07-13 |
| JP2023530120A5 true JP2023530120A5 (https=) | 2024-01-15 |
Family
ID=79268240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022576866A Pending JP2023530120A (ja) | 2020-06-15 | 2021-01-08 | 血管性認知症を治療するためのＲｈｏキナーゼ阻害剤の使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230285409A1 (https=) |
| EP (1) | EP4164652A4 (https=) |
| JP (1) | JP2023530120A (https=) |
| CN (1) | CN116249532A (https=) |
| CA (1) | CA3180411A1 (https=) |
| MX (1) | MX2022015800A (https=) |
| WO (1) | WO2021257122A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240423998A1 (en) | 2021-11-29 | 2024-12-26 | Woolsey Pharmaceuticals, Inc. | Methods of treating agitation and other dementia-associated behavioral symptoms |
| WO2024243197A2 (en) * | 2023-05-24 | 2024-11-28 | Woolsey Pharmaceuticals, Inc. | Method of treating patients with notch3 mutations |
| WO2025024104A2 (en) * | 2023-07-06 | 2025-01-30 | Woolsey Pharmaceuticals, Inc. | Method for reducing caregiver burden associated with alzheimer's disease |
| WO2025101834A1 (en) * | 2023-11-10 | 2025-05-15 | Woolsey Pharmaceuticals, Inc. | Methods of treating sporadic cerebral small vessel disease |
| CN119954776A (zh) * | 2025-03-03 | 2025-05-09 | 中国药科大学 | 一种法舒地尔二氯乙酸盐的制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005117896A1 (de) * | 2004-06-03 | 2005-12-15 | Schering Aktiengesellschaft | Formulierungen, die fasudil, eine matrix und einem mantel enthalten |
| WO2008019395A2 (en) * | 2006-08-10 | 2008-02-14 | Translational Genomics Research Institute | Compounds for improving learning and memory |
| US8648069B2 (en) * | 2007-06-08 | 2014-02-11 | Abbvie Inc. | 5-substituted indazoles as kinase inhibitors |
| EP2285217A4 (en) * | 2008-05-12 | 2011-06-08 | Amnestix Inc | CONNECTIONS TO IMPROVE LEARNING AND MEMORY |
| RU2014104690A (ru) * | 2011-08-12 | 2015-09-20 | Е.Р.Д.Е.-ААК-Диагностик ГмбХ | АГОНИСТИЧЕСКИЕ АУТОАНТИТЕЛА К α1- И β2-АДРЕНЕРГИЧЕСКИМ РЕЦЕПТОРАМ ПРИ БОЛЕЗНИ АЛЬЦГЕЙМЕРА И СОСУДИСТОЙ ДЕМЕНЦИИ |
| WO2013066151A1 (en) * | 2011-10-31 | 2013-05-10 | N.V. Nutricia | Improving recognition |
| US20150297679A1 (en) * | 2012-12-14 | 2015-10-22 | The Brigham And Women's Hospital, Inc. | Methods and assays relating to macrophage differentiation |
| MX2022008513A (es) * | 2020-01-09 | 2022-08-08 | Woolsey Pharmaceuticals Inc | Metodos para tratar la deambulacion asociada con la demencia cortical. |
| US20230080958A1 (en) * | 2020-02-10 | 2023-03-16 | Woolsey Pharmaceuticals, Inc. | Methods of treating pseudobulbar affect and other emotional disturbances |
-
2021
- 2021-01-08 CN CN202180059786.2A patent/CN116249532A/zh active Pending
- 2021-01-08 EP EP21824978.7A patent/EP4164652A4/en active Pending
- 2021-01-08 CA CA3180411A patent/CA3180411A1/en active Pending
- 2021-01-08 WO PCT/US2021/012590 patent/WO2021257122A1/en not_active Ceased
- 2021-01-08 MX MX2022015800A patent/MX2022015800A/es unknown
- 2021-01-08 JP JP2022576866A patent/JP2023530120A/ja active Pending
- 2021-01-08 US US18/001,514 patent/US20230285409A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023530120A5 (https=) | ||
| KR101125462B1 (ko) | 모다피닐의 제약 제제 | |
| CN1074920C (zh) | 止痛剂及其应用 | |
| JP4771937B2 (ja) | 重症心不全の治療方法およびその薬剤 | |
| JP2006506378A5 (https=) | ||
| JP2023523706A5 (https=) | ||
| MD3347002T2 (ro) | Tratamentul bolii Alzheimer într-o populație specifică de pacienți | |
| JP2023539405A (ja) | アルツハイマー病およびパーキンソン病を処置するための組成物および方法 | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| JP2023533289A (ja) | 閉塞性睡眠時無呼吸（ｏｓａ）の治療のための組成物および方法 | |
| JP2011079854A (ja) | 洞房結節Ｉｆ電流阻害剤およびアンギオテンシン変換酵素阻害剤の新規な組み合わせならびにそれを含む医薬組成物 | |
| JP2004519424A5 (ja) | インシュリン分泌促進剤およびＨＭＧ−Ｃｏ−Ａレダクターゼ阻害剤およびＡＣＥ阻害剤から選択される活性成分を含む組み合わせ | |
| JP2001510800A (ja) | 注意欠損／活動亢進症の治療のためのアルカノイルカルニチン誘導体の使用 | |
| TW202237103A (zh) | 用於治療抑鬱症的ｎｒ２ｂ－ｎｍｄａ受體ｎａｍ之劑量方案 | |
| KR100692235B1 (ko) | 안지오텐신 ⅱ 길항물질의 신규한 용도 | |
| JP2024523406A5 (https=) | ||
| CN101015556A (zh) | 窦房结If电流抑制剂与钙抑制剂的新组合以及含有它的药物组合物 | |
| KR100895031B1 (ko) | 지질 농후 플라크의 감소, 안정화 및 파열 방지 방법 | |
| WO2017022787A1 (ja) | 収縮力低下随伴性排尿筋過活動改善剤 | |
| JP2022526755A (ja) | 化合物バフィデムスタット（ｖａｆｉｄｅｍｓｔａｔ）などｋｄｍ１ａ阻害剤を使用した注意欠陥多動性障害の処置方法 | |
| JP2022525679A (ja) | 境界性パーソナリティ障害の処置方法 | |
| JP6894555B1 (ja) | 排尿症状治療剤 | |
| JP7034314B2 (ja) | うつ病を予防または治療するための安息香酸またはその塩および誘導体 | |
| HK1106444B (en) | New association of a sinus node if current inhibitor and an angiotensin-converting enzyme inhibitor, and pharmaceutical compositions containing it | |
| JP2005527634A (ja) | 緊張型頭痛の治療にミルナシプランを使用する方法 |